D-beta-hydroxybutyrate extends lifespan in C. elegans

Aging

Volumn 6, Issue 8, 2014, Pages 621-644

  Edwards, Clare ^a   Canfield, John ^a   Copes, Neil ^a   Rehan, Muhammad ^a   Lipps, David ^a   Bradshaw, Patrick C ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Aging; Beta hydroxybutyrate; C. elegans; Ketone bodies; Lifespan; Mitochondria

Indexed keywords

3 HYDROXYBUTYRIC ACID; HISTONE DEACETYLASE; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3;

ANIMAL; CAENORHABDITIS ELEGANS; DRUG EFFECTS; GENETICS; LONGEVITY; METABOLISM; PHYSIOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

3-HYDROXYBUTYRIC ACID; ANIMALS; CAENORHABDITIS ELEGANS; HISTONE DEACETYLASE 2; HISTONE DEACETYLASES; LONGEVITY; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 84907089341     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100683     Document Type: Article

References (102)

1. Ahlqvist KJ, Hamalainen RH, Yatsuga S, Uutela M, Terzioglu M, Gotz A, Forsstrom S, Salven P, Angers-Loustau A, Kopra OH, Tyynismaa H, Larsson NG, Wartiovaara K, et al. Somatic progenitor cell vulnerability to mitochondrial DNA mutagenesis underlies progeroid phenotypes in Polg mutator mice. Cell Metab. 2012; 15:100-109.
2. Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE, Bohlooly YM, Gidlof S, Oldfors A, Wibom R, Tornell J, Jacobs HT and Larsson NG. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature. 2004; 429:417-423.
3. Braeckman BP, Houthoofd K, De Vreese A and Vanfleteren JR. Apparent uncoupling of energy production and consumption in long-lived Clk mutants of Caenorhabditis elegans. Curr Biol. 1999; 9:493-496.
4. Dell'agnello C, Leo S, Agostino A, Szabadkai G, Tiveron C, Zulian A, Prelle A, Roubertoux P, Rizzuto R and Zeviani M. Increased longevity and refractoriness to Ca(2+)-dependent neurodegeneration in Surf1 knockout mice. Hum Mol Genet. 2007; 16:431-444.
5. Copeland JM, Cho J, Lo T, Jr., Hur JH, Bahadorani S, Arabyan T, Rabie J, Soh J and Walker DW. Extension of Drosophila life span by RNAi of the mitochondrial respiratory chain. Curr Biol. 2009; 19:1591-1598.
6. Hansen M, Hsu AL, Dillin A and Kenyon C. New genes tied to endocrine, metabolic, and dietary regulation of lifespan from a Caenorhabditis elegans genomic RNAi screen. PLoS genetics. 2005; 1:119-128.
7. Hansford RG, Hogue BA and Mildaziene V. Dependence of H2O2 formation by rat heart mitochondria on substrate availability and donor age. J Bioenerg Biomembr. 1997; 29:89-95.
8. St-Pierre J, Buckingham JA, Roebuck SJ and Brand MD. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J Biol Chem. 2002; 277:44784-44790.
9. Harman D. Origin and evolution of the free radical theory of aging: a brief personal history, 1954-2009. Biogerontology. 2009; 10:773-781.
10. Greer EL and Brunet A. Different dietary restriction regimens extend lifespan by both independent and overlapping genetic pathways in C. elegans. Aging Cell. 2009; 8:113-127.
11. Ingram DK, Anson RM, de Cabo R, Mamczarz J, Zhu M, Mattison J, Lane MA and Roth GS. Development of calorie restriction mimetics as a prolongevity strategy. Ann N Y Acad Sci. 2004; 1019:412-423.
12. Kenyon C. A conserved regulatory system for aging. Cell. 2001; 105:165-168.
13. Newman JC and Verdin E. Ketone bodies as signaling metabolites. Trends Endocrinol Metab. 2014; 25:42-52.
14. Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, Grueter CA, Lim H, Saunders LR, Stevens RD, Newgard CB, Farese RV, Jr., de Cabo R, et al. Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science. 2013; 339:211-214.
15. Panov A, Orynbayeva Z, Vavilin V and Lyakhovich V. Fatty acids in energy metabolism of the central nervous system. Biomed Res Int. 2014; 2014:472459.
16. Liu Z, Ciocea A and Devireddy L. Endogenous siderophore 2,5-dihydroxybenzoic acid deficiency promotes anemia and splenic iron overload in mice. Mol Cell Biol. 2014; 34:2533-2546.
17. Mercken EM, Carboneau BA, Krzysik-Walker SM and de Cabo R. Of mice and men: the benefits of caloric restriction, exercise, and mimetics. Ageing Res Rev. 2012; 11:390-398.
18. Pasinetti GM, Zhao Z, Qin W, Ho L, Shrishailam Y, Macgrogan D, Ressmann W, Humala N, Liu X, Romero C, Stetka B, Chen L, Ksiezak-Reding H, et al. Caloric intake and Alzheimer's disease. Experimental approaches and therapeutic implications. Interdiscip Top Gerontol. 2007; 35:159-175.
19. Smith MA, Drew KL, Nunomura A, Takeda A, Hirai K, Zhu X, Atwood CS, Raina AK, Rottkamp CA, Sayre LM, Friedland RP and Perry G. Amyloid-beta, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs? Neurochem Int. 2002; 40:527-531.
20. Dragicevic N, Mamcarz M, Zhu Y, Buzzeo R, Tan J, Arendash GW and Bradshaw PC. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice. J Alzheimers Dis. 2010; 20 Suppl 2:S535-550.
21. Kashiwaya Y, Takeshima T, Mori N, Nakashima K, Clarke K and Veech RL. d-β-Hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proceedings of the National Academy of Sciences. 2000; 97:5440-5444.
22. Van der Auwera I, Wera S, Van Leuven F and Henderson ST. A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease. Nutr Metab (Lond). 2005; 2:28.
23. Brownlow ML, Benner L, D'Agostino D, Gordon MN and Morgan D. Ketogenic diet improves motor performance but not cognition in two mouse models of Alzheimer's pathology. PLoS One. 2013; 8:e75713.
24. Zhang J, Cao Q, Li S, Lu X, Zhao Y, Guan JS, Chen JC, Wu Q and Chen GQ. 3-Hydroxybutyrate methyl ester as a potential drug against Alzheimer's disease via mitochondria protection mechanism. Biomaterials. 2013; 34:7552-7562.
25. Reger MA, Henderson ST, Hale C, Cholerton B, Baker LD, Watson GS, Hyde K, Chapman D and Craft S. Effects of betahydroxybutyrate on cognition in memory-impaired adults. Neurobiol Aging. 2004; 25:311-314.
26. Cole NB, Dieuliis D, Leo P, Mitchell DC and Nussbaum RL. Mitochondrial translocation of alpha-synuclein is promoted by intracellular acidification. Exp Cell Res. 2008; 314:2076-2089.
27. Devi L, Raghavendran V, Prabhu BM, Avadhani NG and Anandatheerthavarada HK. Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem. 2008; 283:9089-9100.
28. Nunomura A, Tamaoki T, Tanaka K, Motohashi N, Nakamura M, Hayashi T, Yamaguchi H, Shimohama S, Lee HG, Zhu X, Smith MA and Perry G. Intraneuronal amyloid beta accumulation and oxidative damage to nucleic acids in Alzheimer disease. Neurobiol Dis. 2010; 37:731-737.
29. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol. 2001; 60:759-767.
30. Tieu K, Perier C, Caspersen C, Teismann P, Wu DC, Yan SD, Naini A, Vila M, Jackson-Lewis V, Ramasamy R and Przedborski S. D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. J Clin Invest. 2003; 112:892-901.
31. Jabre MG and Bejjani BP. Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study. Neurology. 2006; 66:617; author reply 617.
32. Evason K, Collins JJ, Huang C, Hughes S and Kornfeld K. Valproic acid extends Caenorhabditis elegans lifespan. Aging Cell. 2008; 7:305-317.
33. Zhang M, Poplawski M, Yen K, Cheng H, Bloss E, Zhu X, Patel H and Mobbs CV. Role of CBP and SATB-1 in aging, dietary restriction, and insulin-like signaling. PLoS Biol. 2009; 7:e1000245.
34. Davie JR. Inhibition of histone deacetylase activity by butyrate. J Nutr. 2003; 133:2485S-2493S.
35. Choi KY, Ji YJ, Jee C, Kim DH and Ahnn J. Characterization of CeHDA-7, a class II histone deacetylase interacting with MEF-2 in Caenorhabditis elegans. Biochem Biophys Res Commun. 2002; 293:1295-1300.
36. Wollam J, Magner DB, Magomedova L, Rass E, Shen Y, Rottiers V, Habermann B, Cummins CL and Antebi A. A novel 3-hydroxysteroid dehydrogenase that regulates reproductive development and longevity. PLoS Biol. 2012; 10:e1001305.
37. Baker ME. Evolution of mammalian 11beta- and 17betahydroxysteroid dehydrogenases-type 2 and retinol dehydrogenases from ancestors in Caenorhabditis elegans and evidence for horizontal transfer of a eukaryote dehydrogenase to E. coli. J Steroid Biochem Mol Biol. 1998; 66:355-363.
38. Chetyrkin SV, Belyaeva OV, Gough WH and Kedishvili NY. Characterization of a novel type of human microsomal 3alpha -hydroxysteroid dehydrogenase: unique tissue distribution and catalytic properties. J Biol Chem. 2001; 276:22278-22286.
39. Marcotte EM, Xenarios I, van Der Bliek AM and Eisenberg D. Localizing proteins in the cell from their phylogenetic profiles. Proc Natl Acad Sci U S A. 2000; 97:12115-12120.
40. Suh J and Hutter H. A survey of putative secreted and transmembrane proteins encoded in the C. elegans genome. BMC Genomics. 2012; 13:333.
41. Glover-Cutter KM, Lin S and Blackwell TK. Integration of the unfolded protein and oxidative stress responses through SKN-1/Nrf. PLoS Genet. 2013; 9:e1003701.
42. Oliveira RP, Porter Abate J, Dilks K, Landis J, Ashraf J, Murphy CT and Blackwell TK. Condition-adapted stress and longevity gene regulation by Caenorhabditis elegans SKN-1/Nrf. Aging Cell. 2009; 8:524-541.
43. Zarse K, Schmeisser S, Groth M, Priebe S, Beuster G, Kuhlow D, Guthke R, Platzer M, Kahn CR and Ristow M. Impaired insulin/IGF1 signaling extends life span by promoting mitochondrial L-proline catabolism to induce a transient ROS signal. Cell Metab. 2012; 15:451-465.
44. Edwards CB, Copes N, Brito AG, Canfield J and Bradshaw PC. Malate and fumarate extend lifespan in Caenorhabditis elegans. PLoS One. 2013; 8:e58345.
45. Choe KP, Leung CK and Miyamoto MM. Unique structure and regulation of the nematode detoxification gene regulator, SKN-1: implications to understanding and controlling drug resistance. Drug Metab Rev. 2012; 44:209-223.
46. Choe KP, Przybysz AJ and Strange K. The WD40 repeat protein WDR-23 functions with the CUL4/DDB1 ubiquitin ligase to regulate nuclear abundance and activity of SKN-1 in Caenorhabditis elegans. Mol Cell Biol. 2009; 29:2704-2715.
47. Zhang Y, Shao Z, Zhai Z, Shen C and Powell-Coffman JA. The HIF-1 hypoxia-inducible factor modulates lifespan in C. elegans. PLoS One. 2009; 4:e6348.
48. Hewitson KS, Lienard BM, McDonough MA, Clifton IJ, Butler D, Soares AS, Oldham NJ, McNeill LA and Schofield CJ. Structural and mechanistic studies on the inhibition of the hypoxiainducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates. J Biol Chem. 2007; 282:3293-3301.
49. Koivunen P, Hirsila M, Remes AM, Hassinen IE, Kivirikko KI and Myllyharju J. Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. J Biol Chem. 2007; 282:4524-4532.
50. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 2001; 107:43-54.
51. Yoneda T, Benedetti C, Urano F, Clark SG, Harding HP and Ron D. Compartment-specific perturbation of protein handling activates genes encoding mitochondrial chaperones. J Cell Sci. 2004; 117:4055-4066.
52. Stringham EG, Dixon DK, Jones D and Candido EP. Temporal and spatial expression patterns of the small heat shock (hsp16) genes in transgenic Caenorhabditis elegans. Mol Biol Cell. 1992; 3:221-233.
53. Hansen M, Taubert S, Crawford D, Libina N, Lee SJ and Kenyon C. Lifespan extension by conditions that inhibit translation in Caenorhabditis elegans. Aging Cell. 2007; 6:95-110.
54. Rousakis A, Vlassis A, Vlanti A, Patera S, Thireos G and Syntichaki P. The general control nonderepressible-2 kinase mediates stress response and longevity induced by target of rapamycin inactivation in Caenorhabditis elegans. Aging Cell. 2013; 12:742-751.
55. Gallinetti J, Harputlugil E and Mitchell JR. Amino acid sensing in dietary-restriction-mediated longevity: roles of signaltransducing kinases GCN2 and TOR. Biochem J. 2013; 449:1-10.
56. Baker BM, Nargund AM, Sun T and Haynes CM. Protective coupling of mitochondrial function and protein synthesis via the eIF2alpha kinase GCN-2. PLoS Genet. 2012; 8:e1002760.
57. Korta DZ, Tuck S and Hubbard EJ. S6K links cell fate, cell cycle and nutrient response in C. elegans germline stem/progenitor cells. Development. 2012; 139:859-870.
58. Li W, DeBella LR, Guven-Ozkan T, Lin R and Rose LS. An eIF4E-binding protein regulates katanin protein levels in C. elegans embryos. J Cell Biol. 2009; 187:33-42.
59. Hartman PS, Ishii N, Kayser EB, Morgan PG and Sedensky MM. Mitochondrial mutations differentially affect aging, mutability and anesthetic sensitivity in Caenorhabditis elegans. Mech Ageing Dev. 2001; 122:1187-1201.
60. Ishii N, Fujii M, Hartman PS, Tsuda M, Yasuda K, Senoo-Matsuda N, Yanase S, Ayusawa D and Suzuki K. A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes. Nature. 1998; 394:694-697.
61. Lublin A, Isoda F, Patel H, Yen K, Nguyen L, Hajje D, Schwartz M and Mobbs C. FDA-approved drugs that protect mammalian neurons from glucose toxicity slow aging dependent on cbp and protect against proteotoxicity. PLoS One. 2011; 6:e27762.
62. Lee S-J, Murphy CT and Kenyon C. Glucose Shortens the Life Span of C. elegans by Downregulating DAF-16/FOXO Activity and Aquaporin Gene Expression. Cell Metabolism. 2009; 10:379-391.
63. Schlotterer A, Kukudov G, Bozorgmehr F, Hutter H, Du X, Oikonomou D, Ibrahim Y, Pfisterer F, Rabbani N, Thornalley P, Sayed A, Fleming T, Humpert P, et al. C. elegans as model for the study of high glucose- mediated life span reduction. Diabetes. 2009; 58:2450-2456.
64. Schulz TJ, Zarse K, Voigt A, Urban N, Birringer M and Ristow M. Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress. Cell Metab. 2007; 6:280-293.
65. Dostal V and Link CD. Assaying beta-amyloid toxicity using a transgenic C. elegans model. J Vis Exp. 2010.
66. van Ham TJ, Thijssen KL, Breitling R, Hofstra RM, Plasterk RH and Nollen EA. C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging. PLoS Genet. 2008; 4:e1000027.
67. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R and Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997; 388:839-840.
68. Zhao Z, Lange DJ, Voustianiouk A, MacGrogan D, Ho L, Suh J, Humala N, Thiyagarajan M, Wang J and Pasinetti GM. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci. 2006; 7:29.
69. Ash PE, Zhang YJ, Roberts CM, Saldi T, Hutter H, Buratti E, Petrucelli L and Link CD. Neurotoxic effects of TDP-43 overexpression in C. elegans. Hum Mol Genet. 2010; 19:3206-3218.
70. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006; 314:130-133.
71. Maalouf M, Rho JM and Mattson MP. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res Rev. 2009; 59:293-315.
72. Budovskaya YV, Wu K, Southworth LK, Jiang M, Tedesco P, Johnson TE and Kim SK. An elt-3/elt-5/elt-6 GATA transcription circuit guides aging in C. elegans. Cell. 2008; 134:291-303.
73. Yoon JC, Ling AJ, Isik M, Lee DY, Steinbaugh MJ, Sack LM, Boduch AN, Blackwell TK, Sinclair DA and Elledge SJ. GLTSCR2/PICT1 links mitochondrial stress and Myc signaling. Proc Natl Acad Sci U S A. 2014; 111:3781-3786.
74. Piantadosi CA, Carraway MS, Babiker A and Suliman HB. Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1. Circ Res. 2008; 103:1232-1240.
75. Piantadosi CA, Withers CM, Bartz RR, MacGarvey NC, Fu P, Sweeney TE, Welty-Wolf KE and Suliman HB. Heme oxygenase-1 couples activation of mitochondrial biogenesis to antiinflammatory cytokine expression. J Biol Chem. 2011; 286:16374-16385.
76. Athale J, Ulrich A, Chou Macgarvey N, Bartz RR, Welty-Wolf KE, Suliman HB and Piantadosi CA. Nrf2 promotes alveolar mitochondrial biogenesis and resolution of lung injury in Staphylococcus aureus pneumonia in mice. Free Radic Biol Med. 2012; 53:1584-1594.
77. Hashimoto T, Horikawa M, Nomura T and Sakamoto K. Nicotinamide adenine dinucleotide extends the lifespan of Caenorhabditis elegans mediated by sir-2.1 and daf-16. Biogerontology. 2010; 11:31-43.
78. Ved R, Saha S, Westlund B, Perier C, Burnam L, Sluder A, Hoener M, Rodrigues CM, Alfonso A, Steer C, Liu L, Przedborski S and Wolozin B. Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans. J Biol Chem. 2005; 280:42655-42668.
79. Maalouf M, Sullivan PG, Davis L, Kim DY and Rho JM. Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience. 2007; 145:256-264.
80. Okuyama T, Inoue H, Ookuma S, Satoh T, Kano K, Honjoh S, Hisamoto N, Matsumoto K and Nishida E. The ERK-MAPK pathway regulates longevity through SKN-1 and insulin-like signaling in Caenorhabditis elegans. J Biol Chem. 2010; 285:30274-30281.
81. Williams DS, Cash A, Hamadani L and Diemer T. Oxaloacetate supplementation increases lifespan in Caenorhabditis elegans through an AMPK/FOXO-dependent pathway. Aging Cell. 2009; 8:765-768.
82. Chin RM, Fu X, Pai MY, Vergnes L, Hwang H, Deng G, Diep S, Lomenick B, Meli VS, Monsalve GC, Hu E, Whelan SA, Wang JX, et al. The metabolite alpha-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR. Nature. 2014; 509:397-401.
83. Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR and Thompson CB. ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation. Science. 2009; 324:1076-1080.
84. Marino G, Pietrocola F, Eisenberg T, Kong Y, Malik SA, Andryushkova A, Schroeder S, Pendl T, Harger A, Niso-Santano M, Zamzami N, Scoazec M, Durand S, et al. Regulation of autophagy by cytosolic acetyl-coenzyme a. Mol Cell. 2014; 53:710-725.
85. Madiraju P, Pande SV, Prentki M and Madiraju SR. Mitochondrial acetylcarnitine provides acetyl groups for nuclear histone acetylation. Epigenetics. 2009; 4:399-403.
86. Yamada T, Zhang SJ, Westerblad H and Katz A. {beta}-Hydroxybutyrate inhibits insulin-mediated glucose transport in mouse oxidative muscle. Am J Physiol Endocrinol Metab. 2010; 299:E364-373.
87. Yancy Jr WS, Foy M, Chalecki AM, Vernon MC and Westman EC. A low-carbohydrate, ketogenic diet to treat type 2 diabetes. Nutr Metab (Lond). 2005; 2:34.
88. Tullet JM, Hertweck M, An JH, Baker J, Hwang JY, Liu S, Oliveira RP, Baumeister R and Blackwell TK. Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in C. elegans. Cell. 2008; 132:1025-1038.
89. Robida-Stubbs S, Glover-Cutter K, Lamming DW, Mizunuma M, Narasimhan SD, Neumann-Haefelin E, Sabatini DM and Blackwell TK. TOR signaling and rapamycin influence longevity by regulating SKN-1/Nrf and DAF-16/FoxO. Cell Metab. 2012; 15:713-724.
90. Kashiwaya Y, Takeshima T, Mori N, Nakashima K, Clarke K and Veech RL. D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc Natl Acad Sci U S A. 2000; 97:5440-5444.
91. Tamagno E, Guglielmotto M, Aragno M, Borghi R, Autelli R, Giliberto L, Muraca G, Danni O, Zhu X, Smith MA, Perry G, Jo DG, Mattson MP, et al. Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the betaamyloid precursor protein. J Neurochem. 2008; 104:683-695.
92. Gasior M, Rogawski MA and Hartman AL. Neuroprotective and disease-modifying effects of the ketogenic diet. Behav Pharmacol. 2006; 17:431-439.
93. Henderson ST. Ketone bodies as a therapeutic for Alzheimer's disease. Neurotherapeutics. 2008; 5:470-480.
94. Tieu K, Perier C, Caspersen C, Teismann P, Wu D-C, Yan S-D, Naini A, Vila M, Jackson-Lewis V and Ramasamy R. D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. Journal of Clinical Investigation. 2003; 112:892-901.
95. Bates EA, Victor M, Jones AK, Shi Y and Hart AC. Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity. J Neurosci. 2006; 26:2830-2838.
96. Panowski SH, Wolff S, Aguilaniu H, Durieux J and Dillin A. PHA-4/Foxa mediates diet-restriction-induced longevity of C. elegans. Nature. 2007; 447:550-555.
97. Wolfrum C, Asilmaz E, Luca E, Friedman JM and Stoffel M. Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature. 2004; 432:1027-1032.
98. Fitzgerald VK, Mensack MM, Wolfe P and Thompson HJ. A transfer-less, multi-well liquid culture feeding system for screening small molecules that affect the longevity of Caenorhabditis elegans. Biotechniques. 2009; 47(4 Suppl.):ix-xv.
99. Timmons L and Fire A. Specific interference by ingested dsRNA. Nature. 1998; 395:854-854.
100. Leong SF and Clark JB. Regional enzyme development in rat brain. Enzymes associated with glucose utilization. Biochem J. 1984; 218:131-138.
101. Williamson JR and Corkey BE. Assays of intermediates of the citric acid cycle and related compounds by fluorometric enzyme methods. In: John ML, ed. Methods in Enzymology: Academic Press. 1969; pp. 434-513.
102. Shukla V, Phulara SC, Yadav D, Tiwari S, Kaur S, Gupta MM, Nazir A and Pandey R. Iridoid compound 10-O-trans-pcoumaroylcatalpol extends longevity and reduces alpha synuclein aggregation in Caenorhabditis elegans. CNS Neurol Disord Drug Targets. 2012; 11:984-992.